In the brains of aged humans and cases of Alzheimer disease, deposits of amyloid in senile plaques are located in proximity to nerve processes. The principal component A pathological hallmark of the brains of individuals with Alzheimer disease (AD) is the formation of senile plaques, which consist of abnormal axonal and dendritic processes (neurites) surrounding extracellular deposits of amyloid fibrils (1, 2). The amyloid in plaque cores is composed of a 4-kDa peptide, 8/A4 (3, 4), which is derived by proteolysis from the transmembrane amyloid precursor protein (APP). At least three APP cDNAs have been identified: APP-695, APP-751, and APP-770 (5-8). The latter two APP transcripts encode additional domains that share structural homologies with the Kunitz family of serine protease inhibitors (6-8). In cerebral cortex, APP mRNAs are transcribed actively in neurons (9, 10), but the function of APP isoforms is largely unknown. Moreover, proteolytic events that cleave ,/A4 from APP, leading to amyloid deposition, are not clear (11). However, two prevailing hypotheses, not mutually exclusive, argue for neuronal (4, 12) and vascular (3, 13) origins of ,8/A4, previously termed f-amyloid protein. Evidence for a neuronal origin centers on two principal findings: the topographic distribution of senile plaques within gray matter (4, 12) and the neuronal localization of all APP mRNAs, including high levels of expression of the brain-enriched transcript (APP-695) (9, 14). However, to date, a consistent correlation between levels of APP expression in brain and the distribution of deposits of amyloid has not been clearly established (10, (15) (16) (17) (18) (19) 
A pathological hallmark of the brains of individuals with Alzheimer disease (AD) is the formation of senile plaques, which consist of abnormal axonal and dendritic processes (neurites) surrounding extracellular deposits of amyloid fibrils (1, 2) . The amyloid in plaque cores is composed of a 4-kDa peptide, 8/A4 (3, 4) , which is derived by proteolysis from the transmembrane amyloid precursor protein (APP). At least three APP cDNAs have been identified: APP-695, APP-751, and APP-770 (5) (6) (7) (8) . The latter two APP transcripts encode additional domains that share structural homologies with the Kunitz family of serine protease inhibitors (6) (7) (8) . In cerebral cortex, APP mRNAs are transcribed actively in neurons (9, 10) , but the function of APP isoforms is largely unknown. Moreover, proteolytic events that cleave ,/A4 from APP, leading to amyloid deposition, are not clear (11) . However, two prevailing hypotheses, not mutually exclusive, argue for neuronal (4, 12) and vascular (3, 13) origins of ,8/A4, previously termed f-amyloid protein. Evidence for a neuronal origin centers on two principal findings: the topographic distribution of senile plaques within gray matter (4, 12) and the neuronal localization of all APP mRNAs, including high levels of expression of the brain-enriched transcript (APP-695) (9, 14) . However, to date, a consistent correlation between levels of APP expression in brain and the distribution of deposits of amyloid has not been clearly established (10, [15] [16] [17] [18] [19] .
The rationale for the present investigation is based on the hypothesis that, if /8/A4 is derived from neuronal APP and is deposited at locations remote from the site of synthesis, APP must be translocated from perikarya to distal terminals in proximity to sites of amyloid deposition. Because APP is a membrane-associated glycoprotein (5, 20, 21) , the fast axonal transport of membrane components (22) is a mechanism by which APP can reach neurites that surround extracellular deposits of amyloid. Therefore, we suggest that APP, axonally transported from perikarya to neuritic endings, is aberrantly processed at sites of amyloid deposition to form parenchymal 8/A4 (11) . In this study, we used an experimental paradigm that involved axonal blockage by nerve ligation in combination with three immunodetection methods to examine the anterograde transport of APP within peripheral nerves. Our findings suggest that APP, synthesized in rodent peripheral sensory neurons, is transported within axons by the fast anterograde system.
MATERIALS AND METHODS
Adult Sprague-Dawley rats (200-250 g) were anesthetized with 4% chloral hydrate i.p., and the sciatic nerve was exposed at the level of the hip flexure =3 cm distal to the L4-L5 dorsal root ganglia (DRG). Two ligations, 8-10 mm apart, were placed on the sciatic nerve with surgical sutures. The wound was closed, and animals were allowed to recover for various times. Subsequently, ligated sciatic nerves were used for immumoblotting or immunocytochemistry. In addition, the sciatic nerve was transected before nerve ligation in one group of animals. In these animals, a 5-mm segment of sciatic nerve was transected ="1 cm distal to the L4-L5 DRG. Six days later, the sciatic nerve distal to the transection was ligated as before, and the tissue was harvested 24 hr later for analysis.
For immunoblotting, two to five animals from the ligated group were sacrificed at 6, 12, 24, or48 hr after ligations. Equal segments of sciatic nerve (4-5 mm) were homogenized in 2 x Laemmli buffer, fractionated in denaturing polyacrylamide gels (7% isocratic or 3-20% gradient gels), and transferred to nitrocellulose membranes. The membranes were incubated with an anti-APP monoclonal antibody (22C11) specific to the N-terminal region of all APP isoforms (21) nique (23) with diaminobenzidine as the chromogen was used to detect the primary antibody. Blots incubated with the radiolabeled antibody were exposed to x-ray films. Subsequently, the band corresponding to the APP signal in each nerve segment was excised from the membranes, and radioactivity (dpm) was determined in a y counter. Pulse labeling of lumbar sensory neurons was carried out by microinjecting the L4 and L5 DRGs with 100 Ci of [35S]methionine (1 Ci = 37 GBq). Two hours later, sciatic nerve ligatures were placed as previously described. In animals sacrificed 20 hr after ligation, 5-mm nerve segments proximal and distal to ligatures were removed and analyzed by immunoprecipitation with a rabbit anti-APP polyclonal antibody (anti-Fd-PreA4) (21) . The immunoprecipitation mixture was subsequently fractionated by SDS/PAGE as described above and exposed to x-ray film after fluorographic enhancement.
The rabbit anti-APP polyclonal antibody (anti-Fd-PreA4) was used for immunocytochemical localization of APP in sciatic nerves that had been doubly ligated as described above. After ligation, nerve segments proximal and distal to ligatures were frozen, and cross sections (10 ,um) of these segments (mounted on glass slides) were incubated with the polyclonal antibody. A goat anti-rabbit secondary antibody, followed by peroxidase-antiperoxidase of rabbit origin and diaminobenzidine, detected APP immunoreactivity in the nerve. Staining was not seen in negative control sections in which the anti-APP primary antibody was replaced by normal rabbit serum.
Acetylcholinesterase activity in the sciatic nerve was analyzed by using [14C]acetylcholine as substrate (24) . Enzyme activity in consecutive 2-mm nerve segments proximal to the first ligature was assayed in three animals at 6, 12, and 24 hr after sciatic nerve ligation, respectively. Ethopropazine (0.1 mM) was added to the incubation mixture to inhibit pseudocholinesterase activity (25) . ['4C]Acetate released in the reaction was recovered by tetraethylboron and tolueneacetonitrile extraction (24) .
homogenates of the DRG and sciatic nerve (Fig. 1) . Heterogeneity in molecular masses of the immunoreactive APP species in these tissues is consistent with reports (21, 26, 27) that the protein is modified posttranslationally. In sciatic nerve, APP was most conspicuous in nerve segments proximal to a ligature placed 6-48 hr previously (Fig. 1) . Specifically, up to 24 hr after ligation, APP accumulated progressively in the segment immediately proximal to the first ligature (Fig. 2A) ; at 48 hr after ligation, there was some attenuation of accumulation of APP. In addition, an extra band of -75-80 kDa was seen in the segment just proximal to the ligature at all postligation time points. It is not clear whether this band of lower intensity represented breakdown products of APP. Accumulation of APP was not observed up to 48 hr after ligation in nerve segments between the two ligatures or in the segment immediately distal to the second ligature, where retrogradely transported material would be detected. These observations are consistent with the fast anterograde transport of APP. The rate of transport was further confirmed by two additional control experiments with constituents carried by fast or slow axonal transport (i.e., acetylcholinesterase or ftubulin, respectively) (22) . Six hours after ligation, the activity of acetylcholinesterase was highest in the nerve segment immediately proximal to the ligature and-progressively increased up to 24 hr after ligation (Fig. 2B) . In contrast, 3-tubulin did not accumulate in proximal nerve segments 24 hr after ligation (data not shown).
Three additional studies were performed to establish that DRG neurons were the ultimate source of APP detected in the sciatic nerve, rather than being derived from sources unrelated (Fig. 3, lane i) .
In the second study, lumbar DRG were microinjected with [35S]methionine, followed 2 hr later by ligations of the sciatic nerve as described previously. Twenty-four hours after ligation, immunoprecipitation of homogenized nerve segments demonstrated an accumulation of labeled APP proximal to -68 the first ligature (Fig. 4) , indicating that the accumulation of APP detected in ligated nerves must have originated from labeled neuronal perikarya.
In the third study, immunocytochemistry localized APP immunoreactivity within axons of the sciatic nerve. One day  FIG. 3 (Fig. 5 A and B) . to axonal transport, such as from the circulation or from local synthesis by Schwann cells. In the first experiment, the proximal sciatic nerve was initially transected near the DRG, and the distal sciatic nerve stump was ligated 6 days later.
Immunoblotting of these ligated nerve segments, which had undergone Wallerian degeneration, revealed two differences.
(i) In contrast to the untransected nerve, APP did not accumulate in the nerve segment immediately proximal to the first ligature. This finding argues against significant local synthesis of APP by nonneuronal cells as a contributor to APP accumulation in nerve segments proximal to the ligature (Fig. 3) .
(ii) Moreover, in these preparations, the composition of proteins detected by the monoclonal antibody was somewhat different and was most readily appreciated in low percentage (7%) isocratic gels. In the ligated but untransected nerve (Fig.  3, lane g ), four sets of bands (75-135 kDa) were found. In contrast, in transected nerves (Fig. 3, lanes b-f) 
DISCUSSION
In aged individuals and in cases of Alzheimer disease, amyloid appears to be deposited preferentially in proximity to neurites, some of which may be remote from perikaryal sites of synthesis (28, 29 (21, 26, 27) and APP molecules lacking the carboxyl-terminal domain are present in human cerebrospinal fluid (21, 33) . Finally, in the brains of aged monkeys, APP immunoreactivity is also present in j/A4-positive plaque cores (30) . Interestingly, within occasional plaques, f3/A4 immunostaining appears to decorate the edges of neurites adjacent to deposits of amyloid. Because P/A4 unassociated with the membrane is highly insoluble (4, 12) and spontaneously self-assembles into amyloid fibrils (34, 36) , the proteolysis of APP and the release of j/A4 into the neuropil are likely to occur at sites of amyloid deposition (11) . Taken together, these observations suggest that one mechanism of amyloidogenesis in brain parenchyma may be the result of alterations in the processing of axonally transported APP that occur at nerve terminals.
Our present understanding of the biological role of APP isoforms, including the isoform specific for the nervous system (APP-695), is incomplete (11, 35) . Because 
